HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through personalized insights, received FDA 510(k) clearance for its 12-lead ECG synthesis software for ...
HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through personalized insights, ...
HeartBeam Receives FDA Clearance for First-Ever, Cable-Free Synthesized 12-Lead ECG for At-Home Arrhythmia Assessment ...
Equimetrics device that weighs 2lbs is being trialled to provide reliable ECG readings and help establish if rate is out of rhythm ...
Abstract: Atrial fibrillation (AF) is a common type of arrhythmia with a high incidence and risk, and it is difficult to monitor. Deep learning-based algorithms for AF detection have made preliminary ...
This article presents a fast and accurate electrocardiogram (ECG) denoising and classification method for low-quality ECG signals. To achieve this, a novel attention-based convolutional denoising ...
Medically reviewed by Christopher Lee, MD Key Takeaways ATTR-CM is a rare, underdiagnosed contributor to heart failure.There is no cure, but newer treatments can slow the progression of the ...
Summary: New research shows that spontaneous eye blinks naturally sync to the beat of music, revealing a hidden form of auditory-motor synchronization that occurs even without conscious movement. In ...